title: [A structural model for psychosocial adjustment in patients with early breast cancer].
abstract: OBJECTIVE
  This study was done to propose a structural model to explain and predict psychosocial adjustment in patients with early breast cancer and to test the model. The model was based on the Stress-Coping Model of Lazarus and Folkman (1984).
  
  
  METHODS
  Data were collected from February 18 to March 18, 2009. For data analysis, 198 data sets were analyzed using SPSS/WIN12 and AMOS 7.0 version.
  
  
  RESULTS
  Social support, uncertainty, symptom experience, and coping had statistically significant direct, indirect and total effects on psychosocial adjustment, and optimism had significant indirect and total effects on psychosocial adjustment. These variables explained 57% of total variance of the psychosocial adjustment in patients with early breast cancer.
  
  
  CONCLUSIONS
  The results of the study indicate a need to enhance psychosocial adjustment of patients with early breast cancer by providing detailed structured information and various symptom alleviation programs to reduce perceived stresses such as uncertainty and symptom experience. They also suggest the need to establish support systems through participation of medical personnel and families in such programs, and to apply interventions strengthening coping methods to give the patients positive and optimistic beliefs.
authors.affiliation: Department of Nursing, Gwangju Women's University, Gwangju, Korea.
authors.forename: Hye Young
authors.initials: HY
authors.lastname: Kim
authors.forename: Hyang Sook
authors.initials: HS
authors.lastname: So
mesh_terms: D000223:Adaptation, Psychological; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000523:psychology* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D008962:Models, Theoretical; D009367:Neoplasm Staging; D012944:Social Support; D011795:Surveys and Questionnaires; D035501:Uncertainty
chemical_list: D000970:Antineoplastic Agents